Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05303753
Other study ID # STUDY00014399
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 26, 2022
Est. completion date July 11, 2022

Study information

Verified date September 2022
Source Arizona State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Healthy participants with self-reported GI complaints will consume the protein supplement that they normally use for recovery purposes after exercise during a 3-week baseline period, followed by a 3-week intervention period in which they maintain usage of their product, but replace a part of this product with a fermented dairy protein with prebiotic fiber. In addition, a group of healthy participants without self-reported GI complaints will serve as a reference group by consuming the protein supplement that they normally use for recovery purposes after exercise during a 3-week period.


Description:

A substantial number of athletes suffer from gastro-intestinal problems, which may impair performance and/or subsequent recovery. Also, gut barrier integrity is impaired with high-intensity training. Emerging studies are showing a positive correlation between the gut microbiome and muscle function, athletic performance, body composition, and natural energy levels. This study will perform an exploratory analysis of the well-being and digestive health of well-trained athletes, and assess the potential effect of fermented dairy protein with prebiotic fiber on these parameters. Question 1: Does the 3-week supplementation of a fermented dairy protein with prebiotic fiber affect the self-reported digestive comfort compared to a 3-week baseline period? And additionally, will the quality of life (self-reported general well-being and states of mood) change with the use of this type of product? Question 2: Does the 3-week supplementation of a fermented dairy protein with prebiotic fiber show an alteration in gut microbiota in comparison to a 3-week baseline period, while dietary intake remains unaffected? Question 3: How is the 3-week supplementation of a fermented dairy protein with prebiotic fiber experienced by the participants (taste and concept liking)? Question 4: Is there a difference in baseline gut microbiota between athletes with and athletes without self-reported GI complaints.


Recruitment information / eligibility

Status Completed
Enrollment 98
Est. completion date July 11, 2022
Est. primary completion date July 11, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Healthy subjects living in Arizona in the USA - Women/Men aged between 18-35 years - Serious athletes (exercise at least 3 x per week) - With or without GI tract issues due to sport or protein/diet intake - 18.5 = BMI = 40 kg/m2 - No physical limitations (i.e. able to perform all activities associated with daily living in an independent manner). - Use of a protein supplement or sports food after at least one training per day 3 x per week - Willing to slightly increase their protein supplement intake during the intervention phase for 21 consecutive days - Stable weight during the last 4 weeks, without a focus on body weight reduction through limiting caloric intake - Written informed consent Exclusion Criteria: - Daily use of (sport) supplements containing probiotics and/or prebiotics - Smoking - Self-reported cow's milk protein allergy - Clinical lactose intolerance - Clinical milk protein allergy - House dust mite allergy - Diagnosed GI tract disorders or diseases - Musculoskeletal disorders - Metabolic disorders (such as diabetes) - Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications). - Chronic use of gastric acid-suppressing medication or anti-coagulants - Use of antibiotics or anti-inflammatory medication the past 2 weeks - Blood donation in the past 2 months - Pregnant/lactating women - Athletes should not aim to lose body weight by reducing energy intake during the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
fermented dairy protein with prebiotic fiber
During the intervention period, the participant will consume a new product and will reduce the amount of protein in their normal diet reflecting the protein content of the new product.

Locations

Country Name City State
United States Arizona State University Phoenix Arizona

Sponsors (2)

Lead Sponsor Collaborator
Arizona State University FrieslandCampina

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in food composition and diet quality Rapid eating assessment in participants (REAP) Baseline (day 0), after 21 days and after 42 days.
Other Change in product experience Question about product experience (taste and concept liking) Baseline (day 0), days 22, 23, 29, 36, 43.
Primary Change in self-reported digestive comfort Gastrointestinal Symptoms Rating Scores (GSRS-score: Average of all 5 sub-scores) Baseline (day 0), after 21 days and after 42 days.
Primary Change in daily self-reported digestive comfort Daily variation of GI complaints (averaged itemized score 1-10) Study period covering day 1 to day 21 compared to day 22-42.
Secondary Change in self-reported general wellbeing - Physical Health Reported as physical wellbeing (Physical Health Questionnaire, PHX - average score 1-7 based on 14 items) Baseline (day 0), after 21 days and after 42 days.
Secondary Change in self-reported general wellbeing - Psychological Distress Reported as psychological distress (mental distress, K6 scale - average score 0-24). Baseline (day 0), after 21 days and after 42 days.
Secondary Change in participants microbiota composition of fecal samples 16s microbial profiling Baseline (day 0), after 21 days and after 42 days.
Secondary Change in dietary intake 24-hour dietary recalls (food group intake, energy and macro- and micronutrient) Baseline (day 0), after 21 days and after 42 days.
Secondary Chane in self-reported states of mood Profile of Mood States (POMS) Baseline (day 0), after 21 days and after 42 days.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT06238557 - Prospective Evaluation of Psychological Consequences and Impact on Long-term Quality of Life
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT05472935 - Asynchronous Mindfulness Based Stress Reduction to Reduce Burnout in Licensed Clinical Social Workers N/A
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Active, not recruiting NCT04746664 - Effects of Nutrition Counselling on Old Age People's Nutritional Status and Quality of Life in Bahir Dar City, North West Ethiopia N/A
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Recruiting NCT04142827 - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) N/A
Active, not recruiting NCT05903638 - A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT03813420 - Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level N/A
Recruiting NCT05550545 - Infant RSV Infections and Health-related Quality of Life of Families
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Recruiting NCT05233020 - Robotic Versus Hybrid Assisted Ventral Hernia Repair N/A
Terminated NCT03304184 - The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life Phase 3
Completed NCT05063305 - Probiotics, Immunity, Stress, and QofL N/A
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A